Acadia Pharmaceuticals (ACAD) Invested Capital (2010 - 2012)

Acadia Pharmaceuticals' Invested Capital history runs 3 years deep, the most recent figure standing at $22000.0 for Q1 2012.

• In Q1 2012, Invested Capital changed N/A year-over-year to $22000.0; the TTM figure through Dec 2012 stood at $22000.0 (down 79.82% YoY), while the FY2011 annual figure was $32000.0, down 58.97% from the prior year.
• Invested Capital for Q1 2012 stood at $22000.0, down from $32000.0 in the prior quarter.
• The five-year high for Invested Capital was $78000.0 in Q4 2010, with the low at $22000.0 in Q1 2012.
• The 3-year median for Invested Capital is $37000.0 (2011), against an average of $41800.0.
• Peak annual rise in Invested Capital reached 58.97% in 2011, while the deepest fall reached 58.97% in 2011.
• Acadia Pharmaceuticals' Invested Capital stood at $78000.0 in 2010, then slumped by 58.97% to $32000.0 in 2011, then plunged by 31.25% to $22000.0 in 2012.
• Business Quant data shows ACAD's Invested Capital at $22000.0 in Q1 2012, $32000.0 in Q4 2011, and $37000.0 in Q3 2011.